Skip to main content
Premium Trial:

Request an Annual Quote

Tony White, Cathy Burzik, James Noble, Alan Aderem, Michael Hanley

Premium
Tony White will remain interim president of Applied Biosystems for one or two more years, White said during a conference call with investors and analysts last week. White, CEO of ABI’s parent company Applera, succeeded Cathy Burzik last October, when she stepped down as president of ABI. “As of now, the board of directors and I have no plans to conduct an external search,” White said in last week’s call. “Rather, we are focusing on further developing the high potential leadership team within Applied Biosystems,” he said.
 

 
CuraGen, parent company of 454 Life Sciences, has appointed James Noble to its board of directors. He will serve as a member of the board’s nominating and governance committee and the audit committee. Noble also serves on the board of GW Pharmaceuticals and the supervisory board of MediGene and is non-executive director of Bionex Investments and of Finsbury Worldwide Pharmaceutical Trust. Prior to that, he was CEO of Avidex.
 
Noble has also served as a non-executive director of Powderject Pharmaceuticals, Oxford Glycosciences, Advanced Medical Solutions, Oxagen, Adprotech Pharmaceuticals, Anthra Pharmaceuticals, PAA, Prolifix, and Neurovex. From 1990 to 1997, Noble was CFO of British Biotech. Prior to that, he was director at Kleinwert Benson.
 

 

Cyntellect this week said it has appointed three new members to its scientific advisory board: Alan Aderem, director of the Institute for Systems Biology and former head of the signal transduction laboratory at Rockefeller University; Charles Cantor, chief scientific officer at Sequenom and former chair and professor of biomedical engineering at Boston University; and Michael Hanley, vice president of discovery research at Amylin Pharmaceuticals and former senior faculty at Imperial College, London.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.